AMPH - Amphastar Pharmaceuticals Inc Debt to Book Capitalization Ratio

Amphastar Pharmaceuticals (AMPH) is implementing environmental standards in the production of inhalers, minimizing harmful emissions and water consumption. The brand is highly valued by US medical centers for the reliability of its emergency resuscitation drugs. The price visualization available on the GURU.Markets page is currently at 0.89. Business stability is ensured by complex dosing technologies and strict FDA requirements, which block inexperienced competitors from entering the market.

As a leader in the production of critical injectable drugs for the B2B sector, Amphastar Pharmaceuticals (AMPH) balances expansion within the generics niche with financial stability. The historical debt-to-book capitalization ratio measures the proportion of borrowed funds relative to equity, demonstrating the trade-off between default risk and the use of leverage to accelerate profits, as this chart clearly reflects.